Regeneron Pharmaceuticals, Inc.
METHODS OF ASSESSING ANTIBODY-DRUG CONJUGATES

Abstract:

The present disclosure provides methods of assessing DAR of ADC products that provide advantages over known methods. Specifically, methods of the disclosure can be used in high-throughput applications and/or without having to dilute ADC samples during the assessment.